BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7858499)

  • 1. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia.
    Montillo M; Tedeschi A; Leoni P
    Leuk Lymphoma; 1994 Sep; 15(1-2):187-8. PubMed ID: 7858499
    [No Abstract]   [Full Text] [Related]  

  • 2. Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia.
    Longo G; Gandini G; Ferrara L; Torelli U; Emilia G
    Eur J Haematol; 1997 Aug; 59(2):124-5. PubMed ID: 9293862
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 4. Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
    Usman M; Adil SN; Sajid R; Khurshid M
    J Pak Med Assoc; 2003 Oct; 53(10):496-7. PubMed ID: 14696895
    [No Abstract]   [Full Text] [Related]  

  • 5. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
    Fujimaki K; Takasaki H; Koharazawa H; Takabayashi M; Yamaji S; Baba Y; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
    Leach M; Parsons RM; Reilly JT; Winfield DA
    Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T; Kovacs MJ
    Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.
    Tosti S; Caruso R; D'Adamo F; Picardi A; Ali Ege M; Girelli G; Mauro FR; Maurillo L; Amadori S
    Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and serological autoimmune complications in chronic lymphocytic leukemia.
    Demir C; Ekinci Ö
    Wien Klin Wochenschr; 2017 Aug; 129(15-16):552-557. PubMed ID: 28477093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
    Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
    Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
    Hamblin TJ; Orchard JA; Myint H; Oscier DG
    J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
    Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
    Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
    Smolej L
    Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
    Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
    Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fludarabine and fatal hemolytic anemia].
    López L; del Villar V; Pascual T
    Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.
    Byrd JC; Hertler AA; Weiss RB; Freiman J; Kweder SL; Diehl LF
    Ann Oncol; 1995 Mar; 6(3):300-1. PubMed ID: 7612497
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
    Aleem A
    Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
    [No Abstract]   [Full Text] [Related]  

  • 20. Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study.
    Montillo M; O'Brien S; Tedeschi A; Byrd JC; Dearden C; Gill D; Brown JR; Barrientos JC; Mulligan SP; Furman RR; Cymbalista F; Plascencia C; Chang S; Hsu E; James DF; Hillmen P
    Blood Cancer J; 2017 Feb; 7(2):e524. PubMed ID: 28157216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.